ctrl K

AI Score

Unlock

Cogent Biosciences Inc. (COGT)

AI Score

Unlock

5.78

-0.21 (-3.51%)

At close: Apr 01, 2025, 3:59 PM

5.97

3.37%

After-hours: Apr 01, 2025, 06:00 PM EDT

Cogent Biosciences Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	n/a	n/a	n/a	n/a	7.87M
Cost of Revenue	n/a	3.59M	5.88M	147K	25.74K
Gross Profit	n/a	-3.59M	-5.88M	-147K	7.85M
Operating Income	-275.94M	-208.13M	-147.84M	-75.55M	-82.2M
Interest Income	18.09M	13.08M	3.99M	467K	144K
Pretax Income	-255.86M	-192.41M	-140.24M	-72.27M	-74.81M
Net Income	-255.86M	-192.41M	-132.64M	-71.81M	-66.45M
Selling & General & Admin	43.28M	34.38M	26.21M	19.64M	17.42M
Research & Development	232.66M	170.17M	121.63M	55.91M	72.65M
Other Expenses	n/a	n/a	3.61M	2.81M	-246K
Operating Expenses	275.94M	208.13M	147.84M	75.55M	90.07M
Interest Expense	n/a	n/a	3.99M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	275.94M	208.13M	147.84M	75.55M	90.07M
Income Tax	n/a	n/a	-7.6M	-467K	-8.36M
Shares Outstanding (Basic)	73.35M	79.66M	58.74M	38.73M	11.08M
Shares Outstanding (Diluted)	73.35M	79.66M	58.74M	38.73M	11.08M
EPS (Basic)	-3.49	-2.42	-2.26	-1.85	-6
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-275.94M	-205.86M	-134.36M	-75.4M	-34.57M
Depreciation & Amortization	n/a	2.27M	5.88M	147K	720K